Blog


Hussman Named "Best Bear Market Money Manager Around" by Money Magazine

In the May issue of Money magazine, they name John Hussman as the Best Bear Market Money Manager Around. The article points to the major advantage of Hussman’s Strategic Growth fund (HSGFX) as being:

Portfolio Update - 03/31/09

By proceeding, I acknowledge that I have read and understood the Disclaimer, Performance Reporting Disclosure and Copyright Statements . Dear clients, As of the close of the first quarter, all of your accounts are up for the year and beating the indexes by a substantial margin. Here is how my performance has stacked up compared to the averages as of the 3/31/09:

Portfolio Update - 02/28/09

By proceeding, I acknowledge that I have read and understood the Disclaimer, Performance Reporting Disclosure and Copyright Statements . Dear Clients, The following is my Performance Update and Outlook for February. All prices and returns are as of 2/28/09.

Portfolio Update - 01/31/09

By proceeding, I acknowledge that I have read and understood the Disclaimer, Performance Reporting Disclosure and Copyright Statements . Dear Clients, The following is my Performance Update and Outlook for January. All prices and returns are as of 1/31/09.

PART I: INTRODUCTION

January, which has historically been a very strong month for equities, saw the S&P 500 deliver its worst January performance on record (source: CBS marketwatch.com) Over the past 12 months, numerous market myths have been destroyed such as:

  • Market always go up in election years…
  • Over time, investors can count on an average return of 10% from equties…
  • The Santa Clause Rally supports stock prices in November through January…
  • In bear markets, stocks typically bottom in September or October…
  • Don’t fight the Fed…

The Wall Street sales machine will be forced back to the drawing board as their clients are growing weary of the lies perpetuated by their financial advisors. Unfortunately for the few clients who stick with the large firms, these titans of finance will be slow to adapt making room for agile advisers who can easily implement new strategies and tactics. For over a decade, Buy and Hold and Efficient Market Theory/Modern Portfolio Theory have failed. Eventually investors will abandon these flawed ideologies and seek new solutions for their retirement dollars.

PART II: ACCOUNT PERFORMANCE

Here is how my performance measured up to the averages as of January 30th of 2009:

PORTFOLIO YTD 2008 2007
MAC’s Core Portfolio 7.6% (8.0%) 12.5%
MAC’s Focus IRA Portfolio1 11.2% (7.3%) 11.0%
MAC’s Focus Margin Portfolio1 5.8% 58.2% 15.0%
S&P 500 (VFINX) (8.4%) (37.0%) 5.4%
NASDAQ 100 (QQQQ) (2.3%) (41.7%) 19.1
Benchmark (3.4%) (19.9%) 8.5%
  1. We implement our Focus Portfolio inside of IRA accounts and margin accounts. In margin accounts, we are able to short sell individual securities providing us with greater opportunities to profit when stocks prices decline. The risk with short selling securities is substantial as it can result in losing more than a 100% of your initial investment. The performance dispersion of our margin accounts is greater than in our IRA accounts due to margin requirements, tax-loss selling and ability to borrow shares to sell short.

We are having a very profitable start to 2009 outperforming my benchmark by 11.0% in the Core Portfolio and 14.6% in my Focus Portfolio – but we had a profitable start to 2008 as well and still suffered losses by year end so I am not taking anything for granted. The good news is that I’ve almost wiped out last year’s losses already. The better news is that the changes I’ve implemented to my Portfolio Management Process (PMP) are working beautifully. Since I began implementing my new trading system in November, your account performance has been as follows:

PORTFOLIO NOV DEC JAN Cumulative
MAC’s Core Portfolio 11.6% 4.7% 7.2% 25.2%
MAC’s Focus Portfolio 13.0% 2.9% 11.1% 29.2%
Wilshire 5000 (VTSMX)1 (7.2%) 1.0% (7.2%) (12.9%)

Since November, the stock market has experienced two down months and one up, yet we have achieved positive returns in all three months. Over that time, my Core Portfolio has outperformed the Wilshire 5000 index by over 38%! Of course three months does not make a sustainable trend. Just because I’ve done well over this short period of time does not guarantee that I will continue to be able to do so.

Portfolio Update - 01/31/09

By proceeding, I acknowledge that I have read and understood the Disclaimer, Performance Reporting Disclosure and Copyright Statements . Dear Clients, The following is my Performance Update and Outlook for January. All prices and returns are as of 1/31/09.

PART I: INTRODUCTION

Last month saw the S&P 500 deliver its worst January performance on record (source: CBS marketwatch.com) Over the past 12 months, numerous market myths have been destroyed such as:

  • Market always go up in election years…
  • Over time, investors can count on an average return of 10% from equties…
  • The Santa Clause Rally supports stock prices in November through January…
  • In bear markets, stocks typically bottom in September or October…
  • Don’t fight the Fed…

The Wall Street sales machine will be forced back to the drawing board as their clients are growing weary of the lies perpetuated by their financial advisors. Unfortunately for the few clients who stick with the large firms, these titans of finance will be slow to adapt making room for agile advisers who can easily implement new strategies and tactics. For over a decade, Buy and Hold and Efficient Market Theory/Modern Portfolio Theory have failed. Eventually investors will abandon these flawed ideologies and seek new solutions for their retirement dollars.

PART II: ACCOUNT PERFORMANCE

Here is how my performance measured up to the averages as of January 30th of 2009:

PORTFOLIO YTD 2008 2007
MAC’s Core Portfolio 7.6% (8.0%) 12.5%
MAC’s Focus Portfolio 11.2% (7.3%) 11.0%
MAC’s Ave. Margin Acct1 6.2% 39.6% 18.3%
S&P 500 (VFINX) (8.4%) (37.0%) 5.4%
NASDAQ 100 (QQQQ) (2.3%) (41.7%) 19.1
Benchmark (3.4%) (19.9%) 8.5%
  1. Average Margin Account performance is simply an average of all of MAC’s margin accounts under discretionary management. There is significant disparity in the performance in these accounts as they are invested in one of MAC’s three primary strategies (Core, Focus or Income). For example, in 2008, the difference between the best and worst account performance was 37.2%. (Best performer returned 60.4% and lowest returned 23.2%) The purpose of exhibiting this information is to show the adviser’s ability to use margin in an account which it does not do in its normal portfolios. The firm does short sell securities in its margin accounts which carries significant risk as it can result in losses in excess to your original investment.

We are having a very profitable start to 2009 outperforming my benchmark by 11.0% in the Core Portfolio and 14.6% in my Focus Portfolio – but we had a profitable start to 2008 as well and still suffered losses by year end so I am not taking anything for granted. The good news is that I’ve almost wiped out last year’s losses already. The better news is that the changes I’ve implemented to my Portfolio Management Process (PMP) are working beautifully. Since I began implementing my new trading system in November, your account performance has been as follows:

PORTFOLIO NOV DEC JAN Cumulative
MAC’s Core Portfolio 11.6% 4.7% 7.2% 25.2%
MAC’s Focus Portfolio 13.0% 2.9% 11.1% 29.2%
Wilshire 5000 (VTSMX) (7.2%) 1.0% (7.2%) (12.9%)

Since November, the stock market has experienced two down months and one up, yet we have achieved positive returns in all three months. Over that time, my Core Portfolio has outperformed the Wilshire 5000 index by over 38%! Of course three months does not make a sustainable trend. Just because I’ve done well over this short period of time does not guarantee that I will continue to be able to do so. Purchase Lotensin Purchase Clonazepam Order Eurax Order Flonase Purchase Acticin Cheap Abana Cheap Micardis Order Aldactone Order Phentrimine Order Aciphex Coumadin Norco Order Amaryl Purchase Arimidex Order Cytotec Order Confido Cheap Lukol Order Aristocort Order Purinethol Order Tenuate Buy Zyprexa Purchase Nimotop Purchase Nizoral Purchase Arava Plendil Shuddha Guggulu Cheap Mexitil Vasotec Cheap Bontril Levothroid Buy Combivent Buy Methocarbam Brite Cheap Serophene Purchase Fosamax Buy Famvir Purchase Mexitil Cheap Celebrex Order Isoptin Lortab Buy Xenacore Order Glucophage Prilosec Order Methocarbam Order Emsam Ambien Purchase Lisinopril Order Prevacid Cheap Oxycontin Flonase Buy Trimox Order Loprox Cheap Atarax Purchase Lamisil Penis Growth Vasodilan Cheap Premarin Female Sexual Purchase StretchNil Purchase Kamagra Cheap Vasotec Buy Tablet Evista Prednisone Purchase Evecare Neurontin Cheap Viramune Cheap Accupril Cheap Isoptin Evecare Xanax Cheap Lexapro Cheap Revia Buy Aricept Risperdal Order Cardizem Purchase Imdur Rimonabant Mevacor Cheap Maxaquin Buy Ionamin Cheap Danazol Buy Motrin Cheap Diakof Cheap Zantac Didronel Serophene Cheap Glucophage Accupril Cheap Snoroff Purchase Cheap Atrovent Order Ionamin Purchase Starlix Buy Avodart Cheap Cialis Cheap Atacand Buy Mobic Purchase Plavix Buy Noroxin Buy Singulair Order Hydrocodone Vicodin Order Didronel Buy Ephedrine Buy Diabecon Cheap Vicodin Avandamet Geriforte Premarin Toprol XL Himcospaz Order Casodex Buy Proventil Purchase Ativan Buy Norco Purchase Watson Buy Synthroid Buy Zovirax Buy Acticin Buy Effects Purchase Isordil Order Procardia Order Rocaltrol Buy Penisole Hytrin Order Monoket Calan Buy Abana Order Clonazepam Buy Premarin Order Oxytrol Methocarbam Purchase Altace Cheap Renalka Purchase Levothroid Buy Ansaid Cheap Risperdal Cheap Rimonabant Abana Order Capoten Orgasm Enhancer Purchase Aciphex Cheap Aricept Buy Ultram Order Risperdal Tenuate Naprosyn Buy Prevacid Order Fioricet Order Biaxin Cheap Flomax Cheap Lincocin Grifulvin V Purchase Lamictal Vytorin Gyne-Lotrimin Buy Urispas Butalbital Buy Ashwagandha Purchase Coreg Cheap Femcare Purchase Didronel Buy Copegus Purchase Vasotec Triphala Purchase Rimonabant Differin Purchase Detrol Purchase Risperdal Order Rogaine Buy Zanaflex Cheap Xeloda Cheap Omnicef Purchase Zetia Buy Miacalcin Order Vantin Purchase Revia Gasex Cheap Fioricet Adipex Touch-Up Kit Order Lynoral Cipro Cheap Rogaine Clarinex Cheap Ephedrine Keftab Cheap Azulfidine Buy Meridia Buy Lioresal Buy Avapro Combivent Buy Rumalaya Buy Lopid Cheap Oxytrol Order Diflucan Cheap Confido Buy Flonase Purchase Sildenafil Purchase Zyban Zyban Nirdosh Purchase Zithromax Purchase Diazepam Viagra Soft Buy Sinequan Buy Nonoxinol Cheap Zyban Purchase Lariam Buy Prescriptions Lynoral Purchase Alprazolam Buy Drug Purchase Lotrisone Cheap Zanaflex Ansaid Cheap Zithromax Pravachol Cheap Nonoxinol Brahmi Buy Alprazolam Lioresal Buy Snoroff Cheap Ambien Buy Lasix Order Parlodel Casodex Order Meridia Ophthacare Purchase Aldactone Buy Adipex Order Elimite Purchase Paxil Purchase Nicotinell Female Viagra Buy Nimotop Buy Trandate Purchase Combivent Purchase Shallaki Purchase Mentax Buy Lasuna Purchase Brite Order Claritin Buy Rhinocort Purchase Zocor Buy Himcospaz Cheap Aciphex Monoket Purchase Atrovent Purchase Elimite Purchase Prilosec Order Endep Cheap Tenuates Purchase Atacand Purchase Lopressor Cheap AyurSlim Cheap Menosan Order Mobic Cheap Dostinex Purchase Carisoprodol Buy Requip Buy Nicotinell Cheap Leukeran Buy Desyrel Buy Lisinopril Acne-n-Pimple Cream Order Serevent Buy Atrovent Order Mycelex-G Buy Brafix Cheap Lopid Purchase Copegus Purchase Bupropion SleepWell (Herbal Purchase Danazol Leukeran Purchase Feldene Order Phentermine Buy Isoptin Imdur Karela Buy Codeine Order Avandamet Order Evista Order Zyvox Purchase Herbolax Order Hoodia Cheap Nimotop Buy Avandamet Order Nonoxinol Cheap Ismo Buy V-Gel Buying Xanax Rythmol SR Purchase Koflet Vantin Cheap Depakote Purchase Acyclovir Cheap Serevent

The End (of Wall Street’s Boom) by Michael Lewis

Michael Lewis recently wrote an article appearing in Conde Nast’s Portfolio.com titled The End which details the root cause of the credit crisis and the ensuing collapse of Wall Street firms like Morgan Stanley and Merrill Lynch. It is a must read by all. When I shorted financials starting in April of ’07, I did not realize how bad things really were, I just knew that whatever the investment banks were doing was not sustainable. I had no idea how the mortgage/CDO market became so enormous and so out of whack. This article does a remarkable job of explaining how such a massive dislocation happened and why. You can read The End of Wall Street’s Boom by clicking on the link.

Portfolio Update - 12/31/08

By proceeding, I acknowledge that I have read and understood the Disclaimer, Performance Reporting Disclosure and Copyright Statements . Dear clients, We finished off the year strong yet I was unable to get your accounts into the black for 2008. Our losses were far less than the great majority of investors, yet I am disappointed in having experienced any losses at all. Here is how my performance has stacked up compared to the averages:

Portfolio Update - 12/31/08

By proceeding, I acknowledge that I have read and understood the Disclaimer, Performance Reporting Disclosure and Copyright Statements . Dear clients, We finished off the year strong yet I was unable to get your accounts into the black for 2008. Our losses were far less than the great majority of investors, yet I am disappointed in having experienced any losses at all. Here is how my performance has stacked up compared to the averages:

Why there is little Hope for Homeowners

Why there is no real solution for the housing market…

There is no quick fix for the housing market for two reasons. First, the investment/speculative demand created over the past decade for homes and mortgage notes caused a massive oversupply of homes which has resulted in their being simply more homes than there are people to live in them. Second, since homes are an extremely durable good, it will be several decades if not generations before the excess supply is worked off.

Why GM, Ford and Chrysler will be bailed out?

By proceeding, I acknowledge that I have read and understood the Disclaimer, Performance Reporting Disclosure and Copyright Statements .

I’ll start this post with a multiple choice question. The government will bail out GM and the other Big 3 for which of the following reasons?

Contact

To discuss your portfolio, please fill out the form below.

WEBSITE DISCLAIMER and COPYRIGHT STATEMENT

McCracken & Company (MAC) is a registered as an Investment Adviser with the State of Texas Securities Board. Our firm's registration with the State of Texas Securities Board is not an endorsement for the firm. The information on this world wide website is for general information purposes only. The MAC is not liable for any decision based on the information of this website. All content expressed herein constitute the judgment of the staff of the MAC. The information contained on this website is from sources that we believe to be reliable however we do not guarantee its accuracy or completeness.

The works of authorship contained in this website in the domain www.investorsadv.com, including but not limited to all design, text, images, charts or other data are owned by McCracken & Company and may not be copied, reproduced, transmitted, displayed, distributed, altered, stored or sublicensed for subsequent use in whole or in part in any manner without written permission from McCracken & Company.